Metabolic / MASLD-MASH Therapies
Metabolic therapies are used to treat metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) by addressing the underlying metabolic factors that contribute to liver damage. These treatments may help reduce excess liver fat, improve inflammation, promote weight loss, and lower the risk of disease progression. Depending on your condition, treatment may include prescription medications, weight management therapies, or metabolic procedures, often combined with lifestyle changes such as a healthy diet and regular physical activity.
Types of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Therapies:
- GLP-1 / Incretin-Based Therapy
- THR-β Agonist Therapy
- Additional Metabolic Therapies
